Novo Nordisk A/S (ADR) (NYSE:NVO)
| CAPS Rating |
|
|---|---|
| Open | $132.79 |
| Previous Close | $135.02 |
| Daily Range | $132.79 - $134.72 |
| 52-Week Range | $94.58 - $135.68 |
| Market Cap | $78.01B |
| P/E Ratio | 19.80 |
| Dividend (Yield) | 1.82 (1.10%) |
| Volume | 173,326 |
| Average Daily Volume | 0 |
NVO
VS S&P 500 (SPY)
How do you think NVO will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
NVO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
NVO News and Commentary
- YCHART OF THE DAY: Facebook’s $75-100 Billion Market Cap on Just $6.3 Billion in Assets: Customers C – YCharts
- Why Did My Stock Just Die? – The Motley Fool
- Novo Nordisk Posts Solid 4Q - Analyst Blog – NASDAQ
- Novo Nordisk Raises Guidance As Earnings Beat Views – SmartMoney
- Novo Nordisk May Perform Stock Split - Chief Financial Officer – SmartMoney
- Novo Nordisk 4Q Net Profit Up 19%, Beats Views, '12 Guidance Raised – SmartMoney
- An Approval. Finally. – The Motley Fool
- Third Time Lucky for Amylin's Bydureon - Analyst Blog – NASDAQ
- Amylin Shares Rise on Diabetes Drug Approval, Challenges Loom – Minyanville
- Amylin Pharmaceuticals Motto: Try, Try, and then Try Again – Blogs @ The Motley Fool
- 2nd UPDATE: FDA Approves Amylin's Bydureon Diabetes Drug After Delays – SmartMoney
- UPDATE: FDA Approves Amylin's Bydureon Diabetes Drug After Delays – SmartMoney
- Will Bydureon Gain FDA Approval? – The Motley Fool
- EARNINGS PREVIEW: New Drugs, FX Key For Europe Pharma Earnings – SmartMoney
- Bristol-Myers/AstraZeneca get CRL - Analyst Blog – NASDAQ
- WSJ BLOG/Health: A.M. Vitals: Pfizer, Medivation End Dimebon Development – SmartMoney
- High-Priced Stocks Worth Every Penny – The Motley Fool
- Amylin Provides Strategy Update - Analyst Blog – NASDAQ
- Novo Nordisk Passes This Key Test – The Motley Fool
- 10 High Margin Healthcare Dividend Shares – Blog at The Motley Fool
RSS Headlines
Fool UK
